Shanghai Kaibao Pharmaceutical (300039) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shanghai Kaibao Pharmaceutical (300039) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥190.98 Million ≈ $27.95 Million USD) by net assets (CN¥4.55 Billion ≈ $665.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Kaibao Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shanghai Kaibao Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300039 current and long-term liabilities for a breakdown of total debt and financial obligations.

Shanghai Kaibao Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Kaibao Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
China Petrochemical Development Corp TW:1314	-0.017x
CW Enerji SA IS:CWENE	-0.008x
V V Food & Beverage Co Ltd SHG:600300	0.083x
CHA Biotech Co. Ltd KQ:085660	-0.043x
Cementos Pacasmayo SAA ADR NYSE:CPAC	0.067x
Shenzhen Absen Optoelectronic Co Ltd SHE:300389	0.210x
SDI Corp TW:2351	0.077x
CNB Financial Corporation NASDAQ:CCNE	0.008x

Annual Cash Flow Conversion Efficiency for Shanghai Kaibao Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Kaibao Pharmaceutical.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.10 Billion ≈ $600.40 Million	CN¥278.95 Million ≈ $40.82 Million	0.068x	-28.35%
2023-12-31	CN¥4.03 Billion ≈ $590.13 Million	CN¥382.66 Million ≈ $56.00 Million	0.095x	-5.19%
2022-12-31	CN¥3.76 Billion ≈ $550.36 Million	CN¥376.42 Million ≈ $55.08 Million	0.100x	+141.71%
2021-12-31	CN¥3.04 Billion ≈ $445.57 Million	CN¥126.08 Million ≈ $18.45 Million	0.041x	-57.41%
2020-12-31	CN¥2.58 Billion ≈ $377.29 Million	CN¥250.65 Million ≈ $36.68 Million	0.097x	-25.23%
2019-12-31	CN¥2.57 Billion ≈ $376.00 Million	CN¥334.09 Million ≈ $48.89 Million	0.130x	+23.16%
2018-12-31	CN¥2.49 Billion ≈ $363.65 Million	CN¥262.36 Million ≈ $38.39 Million	0.106x	+1.62%
2017-12-31	CN¥2.37 Billion ≈ $346.14 Million	CN¥245.76 Million ≈ $35.96 Million	0.104x	-27.40%
2016-12-31	CN¥2.20 Billion ≈ $321.97 Million	CN¥314.88 Million ≈ $46.08 Million	0.143x	-12.25%
2015-12-31	CN¥2.01 Billion ≈ $293.47 Million	CN¥327.08 Million ≈ $47.86 Million	0.163x	+8.85%
2014-12-31	CN¥1.88 Billion ≈ $275.78 Million	CN¥282.38 Million ≈ $41.32 Million	0.150x	-10.95%
2013-12-31	CN¥1.61 Billion ≈ $235.02 Million	CN¥270.23 Million ≈ $39.54 Million	0.168x	-1.89%
2012-12-31	CN¥1.42 Billion ≈ $207.61 Million	CN¥243.32 Million ≈ $35.61 Million	0.171x	+132.79%
2011-12-31	CN¥1.33 Billion ≈ $195.27 Million	CN¥98.31 Million ≈ $14.39 Million	0.074x	+360.54%
2010-12-31	CN¥1.24 Billion ≈ $181.01 Million	CN¥19.79 Million ≈ $2.90 Million	0.016x	-65.23%
2009-12-31	CN¥1.15 Billion ≈ $167.72 Million	CN¥52.74 Million ≈ $7.72 Million	0.046x	-68.76%
2008-12-31	CN¥126.92 Million ≈ $18.57 Million	CN¥18.70 Million ≈ $2.74 Million	0.147x	-51.29%
2007-12-31	CN¥76.96 Million ≈ $11.26 Million	CN¥23.27 Million ≈ $3.41 Million	0.302x	-42.84%
2006-12-31	CN¥37.24 Million ≈ $5.45 Million	CN¥19.70 Million ≈ $2.88 Million	0.529x	--

About Shanghai Kaibao Pharmaceutical

SHE:300039 China Drug Manufacturers - Specialty & Generic

Market Cap

$884.70 Million

CN¥6.05 Billion CNY

Market Cap Rank

#9663 Global

#2705 in China

Share Price

CN¥5.78

Change (1 day)

-0.69%

52-Week Range

CN¥5.62 - CN¥6.96

All Time High

CN¥12.44